tetano
Editor, Senior Moderator
Life Sci
. 2020 May 22;117839.
doi: 10.1016/j.lfs.2020.117839. Online ahead of print.
Coronaviruses Pathogenesis, Comorbidities and Multi-Organ Damage - A Review
KaviyarasiRenu[SUP] 1 [/SUP], Pureti Lakshmi Prasanna[SUP] 1 [/SUP], V G Abilash[SUP] 2 [/SUP]
Affiliations
Abstract
Human coronaviruses, especially COVID-19, is an emerging pandemic infectious disease with high morbidity and mortality. Coronaviruses are associated with comorbidities, along with the symptoms of it. SARS-CoV-2 is one of the highly pathogenic coronaviruses that causes a high death rate compared to the SARS-CoV and MERS. In this review, we focused on the mechanism of coronavirus with comorbidities and impairment in multi-organ function. The main dysfunction upon coronavirus infection is damage to alveolar and acute respiratory failure. It is associated with the other organ damage such as cardiovascular risk via an increased level of hypertension through ACE2, gastrointestinal dysfunction, chronic kidney disease, diabetes mellitus, liver dysfunction, lung injury, CNS risk, ocular risks such as chemosis, conjunctivitis, and conjunctival hyperemia, cancer risk, venous thromboembolism, tuberculosis, aging, and cardiovascular dysfunction and reproductive risk. Along with this, we have discussed the immunopathology and coronaviruses at a molecular level and therapeutic approaches for the coronavirus infection. The comorbidities and multi-organ failure of COVID-19 have been explained at a molecular level along with the base of the SARS-CoV and MERS-CoV. This review would help us to understand the comorbidities associated with the coronaviruses with multi-organ damage.
Keywords: COVID-19; Comorbidities; Multi-organ failure and immunopathology; SARS-CoV-2.
. 2020 May 22;117839.
doi: 10.1016/j.lfs.2020.117839. Online ahead of print.
Coronaviruses Pathogenesis, Comorbidities and Multi-Organ Damage - A Review
KaviyarasiRenu[SUP] 1 [/SUP], Pureti Lakshmi Prasanna[SUP] 1 [/SUP], V G Abilash[SUP] 2 [/SUP]
Affiliations
- PMID: 32450165
- DOI: 10.1016/j.lfs.2020.117839
Abstract
Human coronaviruses, especially COVID-19, is an emerging pandemic infectious disease with high morbidity and mortality. Coronaviruses are associated with comorbidities, along with the symptoms of it. SARS-CoV-2 is one of the highly pathogenic coronaviruses that causes a high death rate compared to the SARS-CoV and MERS. In this review, we focused on the mechanism of coronavirus with comorbidities and impairment in multi-organ function. The main dysfunction upon coronavirus infection is damage to alveolar and acute respiratory failure. It is associated with the other organ damage such as cardiovascular risk via an increased level of hypertension through ACE2, gastrointestinal dysfunction, chronic kidney disease, diabetes mellitus, liver dysfunction, lung injury, CNS risk, ocular risks such as chemosis, conjunctivitis, and conjunctival hyperemia, cancer risk, venous thromboembolism, tuberculosis, aging, and cardiovascular dysfunction and reproductive risk. Along with this, we have discussed the immunopathology and coronaviruses at a molecular level and therapeutic approaches for the coronavirus infection. The comorbidities and multi-organ failure of COVID-19 have been explained at a molecular level along with the base of the SARS-CoV and MERS-CoV. This review would help us to understand the comorbidities associated with the coronaviruses with multi-organ damage.
Keywords: COVID-19; Comorbidities; Multi-organ failure and immunopathology; SARS-CoV-2.